Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Laronidase; Enzymatic replacement therapy; URT infections; Sleep apnea; Hearing lossMucopolissacaridose I; Laronidase; Terapia de reposição enzimática; Infecções do TRS; Apneia do sono; Perda auditiva
مقالات ISI موکوپلیساکاریدوز I (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Hurler syndrome; Cornea; Myofibroblasts; Corneal clouding; CollagenMPS1-H, mucopolysaccharidosis I-Hurler; GAG, glycosaminoglycans; BCVA, best corrected visual acuity; PB, phosphate buffer; PBS, phosphate buffered saline
Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Hematopoietic cell transplantation; Biomarkers; Residual disease activity;
Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I
Keywords: موکوپلیساکاریدوز I; OSAS; obstructive sleep apnea syndrome; MPS I; mucopolysaccharidosis I; HSCT; hematopoietic stem cell transplantation; PSG; polysomnography; AHI; apnea-hypopnea index; GAG; glycosaminoglycan; IDUA; a-L-iduronidase; MPS I-H; Hurler syndrome; MPS I-S; Sch
Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots
Keywords: موکوپلیساکاریدوز I; MPS I; mucopolysaccharidosis I; IDUA; L-iduronidase; LSD; lysosomal storage diseases; DBS; dried blood spots; 4-MU-ID; 4-methylumbelliferyl-α-L-iduronide; TCA; trichloroacetic acid; 4-MU; 4-methylumbelliferone; Lysosomal storage diseases; MPS I; IDUA; Dr
Agile delivery of protein therapeutics to CNS
Keywords: موکوپلیساکاریدوز I; Aβ; amyloid β; Ab-InsR; antibodies against insulin receptor; Ab-TfR; antibodies against transferrin receptor; AD; Alzheimer's disease; Aerosol OT; bis-(2-ethylhexyl) sulfosucciate; ALS; amyotrophic lateral sclerosis; ApoB; apolipoprotein B; ApoE; apolip
High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Hurler; Hurler-Scheie; Scheie; Surgery; Mortality; Anesthetic complications
Laronidase replacement therapy improves myocardial function in mucopolysaccharidosis I
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Laronidase replacement therapy; Myocardial function; Speckle tracking imaging
A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants
Keywords: موکوپلیساکاریدوز I; Cq; quantification cycles; DS; dermatan sulfate; ERT; enzyme replacement therapy; GAGs; glycosaminoglycans; HSCT; hematopoietic stem cell transplantation; HS; heparan sulfate; IDUA; α-l-iduronidase; MPS I; mucopolysaccharidosis type I; PTC; premature ter
Dried Blood Spot Analysis: An Easy and Reliable Tool to Monitor the Biochemical Effect of Hematopoietic Stem Cell Transplantation in Hurler Syndrome Patients
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Hurler syndrome; Hematopoietic stem cell transplantation; Iduronidase; Clinical enzyme tests; Dried blood spot
The carboxy-terminal ER-retention motif, SEKDEL, influences the N-linked glycosylation of recombinant human α-l-iduronidase but has little effect on enzyme activity in seeds of Brassica napus and Nicotiana tabacum
Keywords: موکوپلیساکاریدوز I; Recombinant proteins; Human α-l-iduronidase; Mucopolysaccharidosis I; ER-retention; N-linked glycosylation; Enzyme replacement therapy;
The Clinical Outcome of Hurler Syndrome after Stem Cell Transplantation
Keywords: موکوپلیساکاریدوز I; Hurler Syndrome; Mucopolysaccharidosis I; Stem cell transplantation; Clinical outcome; Long-term outcome
Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Lysosomal storage disorder; Intrathecal; Enzyme replacement therapy; Central nervous system; Cerebrospinal fluid; Hurler; Scheie; Hurler-Scheie; Pachymeningitis;
A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years
Keywords: موکوپلیساکاریدوز I; Cardiac function; Efficacy; Enzyme replacement therapy; Hurler–Scheie; Joint stiffness; Laronidase; Mucopolysaccharidosis I; Scheie
Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy
Keywords: موکوپلیساکاریدوز I; Stem cell; Mice; Mucopolysaccharidosis I; Animal model; Glycosaminoglycans; Iduronidase; Rotarod performance test; Ganglioside
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice
Keywords: موکوپلیساکاریدوز I; FIX; Factor IX; IV; intravenous; hFIX; human FIX; RV; retroviral vector; MPS I; mucopolysaccharidosis I; CTL; cytotoxic T lymphocyte; cIDUA; canine α-l-iduronidase; WPRE; woodchuck hepatitis virus post-transcriptional regulatory element; IU; internationa
Bone marrow transplantation for feline mucopolysaccharidosis I
Keywords: موکوپلیساکاریدوز I; Bone marrow transplantation; Disease models, animal; Lysosomal storage diseases; Iduronidase; Glycosaminoglycans; Mucopolysaccharidosis I
Prediction of neuropathology in mucopolysaccharidosis I patients
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; α-l-Iduronidase; Heparan sulphate; Dermatan sulphate; Oligosaccharides; Central nervous system pathology; Electrospray-ionisation tandem mass spectrometry;
A homology model for human α-l-iduronidase: Insights into human disease
Keywords: موکوپلیساکاریدوز I; Mucopolysaccharidosis I; Human α-iduronidase; Homology model; Xylosidase; Lysosomal storage disorder; Missense mutation; Enzyme replacement therapy; Three-dimensional structure;